Thursday, November 21, 2019 9:33:36 PM
I’m not so sure everything is a go with Allijon. Which may be the poker tell.
Still a ways off with the Car-t and Immunology for investors and trades. 5 years back when it popped it was bc of another Biotech was bought out traders thought cbmg may be next and Cbmg joined the Nasdaq.
I wonder if Cbmg could be the bridge for other Biotech JV’s in the U.S to get access to China? Sort of like the eastbridge model?
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM